Sangamo Therapeutics (SGMOQ) FCF Margin (QoQ) (2010 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) FCF Margin (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Sangamo Therapeutics | 43.74 Mn | 22.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 473,114.00 |
| Sep 30, 2025 | -480,429.00 |
| Jun 30, 2025 | 31,140.00 |
| Mar 31, 2025 | -36,019.00 |
| Dec 31, 2024 | -7,356.00 |
| Sep 30, 2024 | 756,799.00 |
| Jun 30, 2024 | 266,858.00 |
| Mar 31, 2024 | -760,695.00 |
| Dec 31, 2023 | -207,331.00 |
| Sep 30, 2023 | 43,687.00 |
| Jun 30, 2023 | -92,086.00 |
| Mar 31, 2023 | 18,852.00 |
| Dec 31, 2022 | -1,764.00 |
| Sep 30, 2022 | -1,702.00 |
| Jun 30, 2022 | 1,666.00 |
| Mar 31, 2022 | -2,039.00 |
| Dec 31, 2021 | 2,769.00 |
| Sep 30, 2021 | -1,160.00 |
| Jun 30, 2021 | 7,644.00 |
| Mar 31, 2021 | -25,890.00 |